Latest filing published 17 Mar 2026 for Mimedx Group, INC., €77k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
William Frank Hulse IV, listed as chief executive, appears in our data through filings on Mimedx Group, Inc. shares, published by SEC (Form 4). We count 23 filings; the first trade dates from 23 February 2022 and the latest from 13 March 2026.
Sales make up the whole of the open-market record (10 sales, €1.3M). Other entries cover 12 share grants and 1 option exercise.
The latest filing, published on 17 March 2026, reports a share grant of €77k in Mimedx Group, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations